Personalized CBD And THC Preparation Could Help Manage The Painful Side Effects Of Cancer Therapies
A new University of Adelaide trial will explore the use of personalized medicinal cannabis dosing to prevent common and impactful symptoms of treatment in advanced cancer thanks to Federal Government funding of $1.5m.
CANCAN trial – a large clinical study would be conducted to guide clinical practice with the investment offered by the Medical Research Future Fund. Given that cancer therapies are usually very toxic and could lead to several physical and psychosocial symptoms that can negatively impact the quality of life, dose intensity, and survival, the medical cannabis can help patients manage their symptoms.
While patients and advocates of cannabis are enthusiastic in their usage of cannabis, medical professionals are reluctant since there is not enough empirical data. LeafCann Group Pty Ltd, an Adelaide-based, federally licensed, medicinal cannabis company will provide the cannabis medicine to be used in the study. The CANCAN trial will show that targeting gut distress, due to mucosal injury, with medical cannabis will improve patient wellbeing and maintenance of intended dosing. The team plans to work with a personalized CBD and THC preparation that could prevent and manage clusters of related side effects of cancer therapy including detrimental effects to sleep, mood, pain, fatigue, and appetite.
Read Full Article: https://www.healtheuropa.eu
CBD is one of many powerful cannabinoids found in hemp known for helping to support our body and mind. Here at Healing Dragon CBD we do not intend to make unfounded medical claims about the health benefits of CBD. The FDA has not confirmed that CBD cures, treats, or prevents any diseases or conditions. Please take a moment to read our full disclosure statement.